| Literature DB >> 21897331 |
Gerald Both1, Ian Alexander, Sue Fletcher, Tamara J Nicolson, John E J Rasko, Steve D Wilton, Geoff Symonds.
Abstract
This review discusses gene therapy as a new treatment paradigm where genetic material is introduced into cells for therapeutic benefit. The genetic material is the 'drug'. It can have a transient or ongoing effect depending on whether or not the introduced genetic material becomes part of the host cell DNA. Different delivery and gene technologies are chosen by investigators to maximise gene delivery to, and expression within, the target cells appropriate for the disease indication. The presence and expression of the introduced genetic material is monitored by molecular means so that treatment efficacy can be assessed via changes in surrogate and/or actual markers of disease. Of interest to the pathologist will be the approaches being developed for the disease indications highlighted and the monitoring of treatment efficacy.Mesh:
Year: 2011 PMID: 21897331 DOI: 10.1097/PAT.0b013e32834b1dad
Source DB: PubMed Journal: Pathology ISSN: 0031-3025 Impact factor: 5.306